Mark Connors

13PUBLICATIONS

123CO-AUTHORS

Nanotoxicology, health and safetyInnate immunityBiomedical instrumentationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|May 25, 2026

Transgene Expression Kinetics and Replication Potential of Recombinant Adenovirus Serotype 4 in a Mouse Model and its Use as a Herpes Simplex Virus Vaccine.

|Apr 15, 2026

A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders.

Janaki Kuruppu, Julia B Purdy, Cheryl Pauls

|Mar 09, 2026

Safety, immunovirological, and CNS effects of PD-1 inhibition in people with HIV without malignancy.

Lauren B Reoma, Tory P Johnson, Ken Cheung

|Nov 12, 2025

Incorporation of 5-methylcytidine alleviates RIG-I-mediated innate immune responses to a self-amplifying RNA vaccine.

Wataru Akahata, Mai Komori, Amber L Morey

|Jun 03, 2025

Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response.

Kenta Matsuda, Mitra Harrison, Eleanor Wettstein

|Dec 14, 2023

HIV vaccines induce CD8<sup>+</sup> T cells with low antigen receptor sensitivity.

Stephen A Migueles, Danielle M Nettere, Noah V Gavil

Pageof 3

Frequent Collaborators

Nicole Doria-Rose

Stephen A Migueles

Daniel Rogan

Peter D Kwong

Tongqing Zhou

Nathaniel E Wright

Gabriel Ozorowski

Dennis R Burton

Amarendra Pegu

John R Mascola

Frequent Collaborators

Nicole Doria-Rose

Stephen A Migueles

Daniel Rogan

Peter D Kwong